Literature DB >> 24275737

Parents' and sons' beliefs in sexual disinhibition after human papillomavirus vaccination.

Melissa K Mayer1, Paul L Reiter, Rachel A Zucker, Noel T Brewer.   

Abstract

BACKGROUND: The concern that adolescent girls who receive human papillomavirus (HPV) vaccine may be more likely to have sex (ie, sexual disinhibition) has been commonplace in media coverage, but this belief is not held by many parents of adolescent girls. Because no studies have addressed this topic for adolescent boys, we examined parents' and their adolescent sons' beliefs in sexual disinhibition occurring after boys receive HPV vaccine.
METHODS: A national sample of parents of adolescent boys (n = 547) and their sons (aged 15-17 years; n = 176) completed online surveys in fall 2010. We used multi-item scales to measure parents' and sons' beliefs in sexual disinhibition after HPV vaccination. We used multivariate linear regression to identify correlates of beliefs in sexual disinhibition.
RESULTS: Less than a quarter of parents or sons agreed with statements suggesting that HPV vaccination leads to sexual disinhibition among adolescent boys (range, 20%-24%). Parents who had more liberal political affiliations (β = -0.11), had a daughter who had received HPV vaccine (β = -0.12), or had no daughter (β = -0.10) reported weaker beliefs in sexual disinhibition. Parents who reported higher anticipated regret if their sons got HPV vaccine and fainted (β = 0.18) indicated stronger beliefs in sexual disinhibition. Sons who perceived higher peer acceptance of HPV vaccination (β = 0.44) or were Hispanic (β = 0.21) had stronger beliefs in sexual disinhibition.
CONCLUSIONS: Most parents and sons did not believe that HPV vaccination leads to sexual disinhibition among boys. Understanding the characteristics of parents and sons who hold these beliefs may help inform efforts to increase HPV vaccine uptake among boys.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24275737      PMCID: PMC4227592          DOI: 10.1097/OLQ.0000000000000021

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  26 in total

Review 1.  Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel.

Authors:  W Cates
Journal:  Sex Transm Dis       Date:  1999-04       Impact factor: 2.830

2.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2007-03-23

3.  Parental attitudes to pre-pubertal HPV vaccination.

Authors:  Laura A V Marlow; Jo Waller; Jane Wardle
Journal:  Vaccine       Date:  2007-01-22       Impact factor: 3.641

4.  Mothers' and adolescents' beliefs about risk compensation following HPV vaccination.

Authors:  Laura A V Marlow; Alice S Forster; Jane Wardle; Jo Waller
Journal:  J Adolesc Health       Date:  2008-12-06       Impact factor: 5.012

5.  Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors.

Authors:  Carrie M Nielson; Robin B Harris; Roberto Flores; Martha Abrahamsen; Mary R Papenfuss; Eileen F Dunne; Lauri E Markowitz; Anna R Giuliano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-24       Impact factor: 4.254

6.  Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males.

Authors:  Paul L Reiter; Annie-Laurie McRee; Jessica K Pepper; Melissa B Gilkey; Kayoll V Galbraith; Noel T Brewer
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

7.  HPV vaccine acceptability in a rural Southern area.

Authors:  Karah I Fazekas; Noel T Brewer; Jennifer S Smith
Journal:  J Womens Health (Larchmt)       Date:  2008-05       Impact factor: 2.681

Review 8.  Predictors of HPV vaccine acceptability: a theory-informed, systematic review.

Authors:  Noel T Brewer; Karah I Fazekas
Journal:  Prev Med       Date:  2007-06-02       Impact factor: 4.018

9.  Parental attitudes and information needs in an adolescent HPV vaccination programme.

Authors:  R Stretch; S A Roberts; R McCann; D Baxter; G Chambers; H Kitchener; L Brabin
Journal:  Br J Cancer       Date:  2008-11-04       Impact factor: 7.640

10.  Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada.

Authors:  Chantal Sauvageau; Bernard Duval; Vladimir Gilca; France Lavoie; Manale Ouakki
Journal:  BMC Public Health       Date:  2007-10-25       Impact factor: 3.295

View more
  5 in total

Review 1.  Human Papillomavirus Vaccines: Successes and Future Challenges.

Authors:  Samara Perez; Gregory D Zimet; Ovidiu Tatar; Nathan W Stupiansky; William A Fisher; Zeev Rosberger
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

Review 2.  Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research.

Authors:  Monica L Kasting; Gilla K Shapiro; Zeev Rosberger; Jessica A Kahn; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2016-02-10       Impact factor: 3.452

3.  Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study.

Authors:  Robine Donken; Adriana Tami; Mirjam J Knol; Karin Lubbers; Marianne A B van der Sande; Hans W Nijman; Toos Daemen; Willibrord C M Weijmar Schultz; Hester E de Melker
Journal:  BMC Public Health       Date:  2018-07-05       Impact factor: 3.295

4.  HPV vaccination has not increased sexual activity or accelerated sexual debut in a college-aged cohort of men and women.

Authors:  Andrew F Brouwer; Rachel L Delinger; Marisa C Eisenberg; Lora P Campredon; Heather M Walline; Thomas E Carey; Rafael Meza
Journal:  BMC Public Health       Date:  2019-06-25       Impact factor: 4.135

Review 5.  Barriers towards HPV Vaccinations for Boys and Young Men: A Narrative Review.

Authors:  Maria Grandahl; Tryggve Nevéus
Journal:  Viruses       Date:  2021-08-19       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.